BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32595698)

  • 1. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
    Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
    Front Genet; 2020; 11():547. PubMed ID: 32595698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
    Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
    Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis.
    Zheng Y; Hao S; Xiang C; Han Y; Shang Y; Zhen Q; Zhao Y; Zhang M; Zhang Y
    Front Oncol; 2021; 11():592854. PubMed ID: 34178613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of
    Li B; Li X; Yang Q; Jiang Y; Zhang Q; Zhang J; Cui W; Xu F
    Aging (Albany NY); 2024 Feb; 16(3):2953-2977. PubMed ID: 38329443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.
    Li S; Yang R; Sun X; Miao S; Lu T; Wang Y; Wo Y; Jiao W
    Gene; 2018 Dec; 679():398-404. PubMed ID: 30240883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
    Chen S; Duan H; Xie Y; Li X; Zhao Y
    Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
    He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
    Front Oncol; 2021; 11():639600. PubMed ID: 33968738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of glycolysis-related
    Yu H; Yu Z; Qin C; Bian T; Shi M
    J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Wang Y; Wen H; Sun D
    Ann Transl Med; 2022 May; 10(9):519. PubMed ID: 35928739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
    Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
    Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D
    Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
    Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
    PeerJ; 2020; 8():e9530. PubMed ID: 32775050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating
    Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
    Front Oncol; 2021; 11():720302. PubMed ID: 34527588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pan-cancer analysis of the oncogenic role of secreted phosphoprotein 1 (SPP1) in human cancers.
    Liu Y; Ye G; Dong B; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Qi Y
    Ann Transl Med; 2022 Mar; 10(6):279. PubMed ID: 35433956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
    Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
    Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis reveals alcohol dehydrogenase 1C and secreted phosphoprotein 1 for prognostic biomarkers in lung adenocarcinoma.
    Shen XY; Liu XP; Song CK; Wang YJ; Li S; Hu WD
    J Cell Physiol; 2019 Dec; 234(12):22311-22320. PubMed ID: 31074035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
    Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
    Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.